Atipamezole
Mostrando 1-5 de 5 artigos, teses e dissertações.
-
1. Efeitos cardiovasculares da medetomidina e cetamina em Puma concolor e tempo de recuperação após aplicação de ioimbina ou atipamezole
RESUMO O objetivo deste estudo foi avaliar as alterações cardiorrespiratórias causadas pela medetomidina associada à cetamina, e o tempo de recuperação após aplicação intramuscular de atipamezole ou ioimbina em Puma concolor. Para isso, foi realizada a aplicação de medetomidina (100µg/kg) associada à cetamina (5mg/kg) em 11 onças-pardas, sendo
Arq. Bras. Med. Vet. Zootec.. Publicado em: 2020-09
-
2. Estudo comparativo do uso de Medetomidina e Xilazina em gatos e sua reversão com Atipamezole / Comparative study of the use of Medetomidine and Xilazine in cats and its reversion with Atipamezole
The medetomidine is sedative and analgesic of the group of the a2 adrenergic agonist approved for dogs and cats, described now as more potent than the xylazine, an old agonist a2 adrenergic of veterinary use. The main difference among those two agonists is the selectivity to the receptors a2-adrenergics, being the medetomidine considered more selective, chec
Publicado em: 2009
-
3. The antagonistic effects of atipamezole and yohimbine on stress-related neurohormonal and metabolic responses induced by medetomidine in dogs
This study aimed to compare the antagonistic effects of atipamezole (40, 120, and 320 μg/kg, IM), yohimbine (110 μg/kg, IM), and saline on neurohormonal and metabolic responses induced by medetomidine (20 μg/kg, IM). Five beagle dogs were used in each of the 5 experimental groups in randomized order. Blood samples were taken for 6 h. Medetomidine signific
-
4. Regulator of G Protein Signaling Protein Suppression of Gαo Protein-Mediated α2A Adrenergic Receptor Inhibition of Mouse Hippocampal CA3 Epileptiform Activity
Activation of G protein-coupled α2 adrenergic receptors (ARs) inhibits epileptiform activity in the hippocampal CA3 region. The specific mechanism underlying this action is unclear. This study investigated which subtype(s) of α2ARs and G proteins (Gαo or Gαi) are involved in this response using recordings of mouse hippocampal CA3 epileptiform bursts
American Society for Pharmacology and Experimental Therapeutics.
-
5. A review of the physiological effects of α2-agonists related to the clinical use of medetomidine in small animal practice
Medetomidine is a relatively new sedative analgesic drug that is approved for use in dogs in Canada. It is the most potent α2-adrenoreceptor available for clinical use in veterinary medicine and stimulates receptors centrally to produce dose-dependent sedation and analgesia. Significant dose sparing properties occur when medetomidine is combined with other